Responding to domestic price cuts and increased demand volatility, AstraZeneca Wuxi deployed 34 4IR use cases, including AI and algorithms, to enhance manufacturing synchronization and efficiency. The site achieved a 55% increase in output, a 44% reduction in manufacturing lead time, an 80% reduction in non-perfect batches and a 54% improvement in labour productivity.